
IPO Draft Pharma Guidelines Criticized for Legal Errors
IPO's 2026 Draft Guidelines for Pharma Patents contain misquotations and misinterpretations, say experts. Flawed approach risks disrupting patent examination standards.
Latest court orders, judgments, and legal developments from Indian courts — AI-curated and summarized.

IPO's 2026 Draft Guidelines for Pharma Patents contain misquotations and misinterpretations, say experts. Flawed approach risks disrupting patent examination standards.
As of September 30, 2026, the RBI processed 3,011 pending applications under its Citizen’s Charter, reflecting its commitment to public service delivery and accountability in regulatory functions.
SEBI renews recognition of BSE Clearing Limited for three years from October 3, 2026, under the Securities Contracts (Regulation) Act, 1956.
SEBI has upgraded its Document Number Verification System by making subject matter a mandatory field and aligning document numbers with E-Office outward records to enhance authenticity and tracking of official communications.
RBI amends ATM operations guidelines, permitting banks to delegate monitoring of cassette swaps to an Executive Committee, enhancing internal oversight flexibility.
The RBI has withdrawn 268 outdated currency management circulars, consolidating current policy into Master Directions to improve regulatory clarity and reduce compliance burden.
RBI modifies its ATM cassette swap directive, permitting boards of banks to delegate monitoring responsibilities to internal oversight committees. The change enhances operational flexibility while maintaining security standards.
The IPO’s Draft Guidelines for Examination of Pharmaceutical Patent Applications, 2026 face severe criticism for misquoting provisions and misinterpreting patentability standards, raising concerns over examination consistency and legal accuracy.
RBI consolidates bank lending guidelines for Scheduled Castes and Scheduled Tribes, covering planning, monitoring, and reporting obligations.
RBI consolidates and withdraws outdated circulars on currency management, rationalising the regulatory framework for banks.
The IPO's Draft Guidelines for Examination of Pharmaceutical Patent Applications (2026) face criticism for misquoting statutes and introducing inconsistent standards, prompting calls for comprehensive revision before finalisation.
Second Amendment Directions issued for Payments Banks to standardise investment valuation. Ensures consistent and transparent portfolio management.